Status

Stem cell technology in breast cancer: current status and potential applications
Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings ... [...]
1
Like
Save
Neo-Bioscore staging system adds HER2 status for precise prognostic …
A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for ... [...]
6
Like
Save
First Lady wants young girls to challenge the status quo
It's all out there, facts, valid sources, documented incidences. Like you said, people .... a woman or girl. Hell, even her husband recommended cutting prostate cancer research from the 2016 CDC budget, but made sure to keep breast cancer research funded. [...]
1
Like
Save
Current status of active surveillance in prostate cancer.
Active surveillance (AS) is a management strategy involving close monitoring the course of disease with the expectation to intervene if the cancer progress, in a super-selected group of low-risk prostate cancer (PCa) patients. Determining AS candidates ... [...]
5
Like
Save
FDA Breakthrough status for Immunomedics breast cancer candidate
The company's sacituzumab govitecan, or IMMU-132, has received this designation from the FDA for the treatment of patients with triple-negative breast cancer (TNBC) who have failed at least 2 prior therapies for metastatic disease. The Breakthrough ... [...]
4
Like
Save
AstraZeneca's Lynparza Gets Breakthrough Therapy Status
AstraZeneca plcAZN announced that the FDA has granted Breakthrough Therapy designation to its PARP inhibitor, Lynparza (olaparib), for the monotherapy treatment of BRCA1/2 or ATM gene mutated metastatic castration resistant prostate cancer (mCRPC) ... [...]
7
Like
Save
Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of …
Curcumin is an antioxidant agent with both radiosensitizing and radioprotective properties. The aim of the present study was to evaluate the effect of curcumin supplementation on oxidative status of patients with prostate cancer who undergo radiotherapy. [...]
3
Like
Save